CONCLUSIONS: These results from the mixing methods help to summarize and shape the experiences reported by an active microdosing community as promising avenues for future scientific research. According to media reports, microdosing has become increasingly popular, but there is little research in the scientific literature on this practice. Microdose research complements documentation of full doses as clinical treatments are developed and neuropharmacological mechanisms are investigated. The aim of this framework is to inform researchers and clinicians as experimental microdose research begins in earnest in the coming years. The MDBC taxonomy presented here provides information on future research and uses participant reports to identify the highest possible intervention targets, so that research funds can be allocated effectively. We studied differences related to substance dependence and found that users who only use psilocybin are more interested in the benefits of microdose than other users. There have been few reports of adverse events associated with microdose and the experiences of microdosers have not been categorized into community samples. Advantages and challenges of psychedelic microdosing: an empirical code book. By providing the information contained in this document, we do not diagnose, treat, cure, mitigate or prevent any type of disease or medical condition. Before undertaking any natural, integrative or conventional treatment, it is recommended to consult a licensed physician.